ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,518Medicare Part D Prescriptions Filled, Including Refills

Rank: 165 out of 2094

$526K Total Retail Price of All Prescriptions

Rank: 451 out of 2094

255 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 255 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

6% of this provider’s 255 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

3% of this provider’s 7,373 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
FOSINOPRIL SODIUM 491 354 10 1 222
SIMVASTATIN 418 307 2 1
OMEPRAZOLE 383 269 3 4
FAMOTIDINE 358 220 4 34
ZOLPIDEM TARTRATE 325 240 5 14
ALENDRONATE SODIUM 269 201 6 30
AMLODIPINE BESYLATE 254 190 7 2
DIOVAN 251 189 8 13
CARVEDILOL 224 178 9 19
AZITHROMYCIN 217 133 10 27
METOPROLOL TARTRATE 207 175 11 10
ATORVASTATIN CALCIUM 205 148 12 5
LOSARTAN POTASSIUM 190 157 13 17
PROAIR HFA 185 112 14 45
GLYBURIDE-METFORMIN HCL 182 136 R 15 94
ENALAPRIL MALEATE 170 98 16 25
FLUTICASONE PROPIONATE 169 111 17 41
CRESTOR 161 105 18 15
LEVOTHYROXINE SODIUM 160 117 19 3
METFORMIN HCL 157 123 20 8
GABAPENTIN 137 82 21 23
JANUVIA 136 97 22 35
GLIPIZIDE XL 134 101 23 122
FLOVENT HFA 125 67 24 242
MELOXICAM 120 106 25 49
IBUPROFEN 120 40 25 73
TIZANIDINE HCL 114 70 27 254
TRAMADOL HCL 114 67 27 33
FUROSEMIDE 114 89 27 6
CIPROFLOXACIN HCL 104 76 30 81
LISINOPRIL 92 72 31 7
VENTOLIN HFA 91 49 32 132
CLOBETASOL PROPIONATE 90 59 33 160
GLIPIZIDE 87 57 34 82
CLONIDINE HCL 83 63 35 62
CLOPIDOGREL 80 63 36 22
ACTOS 77 68 37 112
MECLIZINE HCL 76 69 38 103
INSULIN SYRINGE 73 51 39 143
EVISTA 72 55 40 131
SERTRALINE HCL 70 62 41 26
NABUMETONE 69 37 42 203
GLIPIZIDE ER 69 40 42 126
HYDROCORTISONE VALERATE 66 43 44 268
PANTOPRAZOLE SODIUM 66 42 44 37
LIPITOR 66 57 44 39
BUSPIRONE HCL 63 25 47 159
DICLOFENAC SODIUM 63 47 47 168
ALBUTEROL SULFATE 59 39 49 90
ADVAIR DISKUS 55 40 50 36
PLAVIX 55 42 50 38
ROPINIROLE HCL 54 44 52 235
ISOSORBIDE MONONITRATE ER 51 36 53 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 28, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.